ASTS
AST SpaceMobile, Inc.
ASTS has the edge over CRNC overall, supported by stronger modeled upside.
CRNC
Cerence Inc.
CRNC has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CRNC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CRNC's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CRNC PE Valuation
CRNC has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CRNC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Stable | |
| Limited | |
| High |
Analysts expect CRNC's earnings and revenue to decline, though with profitability holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CRNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q2 2026 | -$0.31 | +$0.35 |
| Q1 2026 | -$0.40 | +$7.70 |
| Q4 2025 | $0.02 | +$15.24 |
| Q3 2025 | -$0.43 | +$13.69 |
| Q2 2025 | -$0.66 | +$13.26 |
| Q1 2025 | -$8.10 | -$1.27 |
| Q4 2024 | -$15.22 | -$14.40 |
| Q3 2024 | -$14.12 | -$12.72 |
CRNC has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CRNC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CRNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $69.6M | +12% |
| Q1 2026 | $64.2M | -18% |
| Q4 2025 | $115.1M | +126% |
| Q3 2025 | $60.6M | +11% |
| Q2 2025 | $62.2M | -12% |
| Q1 2025 | $78M | +15% |
| Q4 2024 | $50.9M | -63% |
| Q3 2024 | $54.8M | -32% |
CRNC's revenue is recovering but still below its 2023 peak: $70M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 2.7% | +4.2 points |
| Q1 2026 | -3.8% | -26 points |
| Q4 2025 | 25% | +59 points |
| Q3 2025 | -2.9% | +32 points |
| Q2 2025 | -1.5% | +502 points |
| Q1 2025 | 22% | +412 points |
| Q4 2024 | -33% | -76 points |
| Q3 2024 | -35% | -40 points |
CRNC has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CRNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $19.6M | +22% |
| Q1 2026 | $13.6M | +3.8% |
| Q4 2025 | $35.6M | +352% |
| Q3 2025 | $9.7M | +109% |
| Q2 2025 | $16.1M | +33% |
| Q1 2025 | $13.1M | +$13.9M |
| Q4 2024 | $7.9M | +$11.6M |
| Q3 2024 | $4.7M | -52% |
CRNC has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over CRNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CRNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +845K shares |
| 1 year | +10% | +4.5M shares |
| 3 years | +18% | +7.4M shares |
| 5 years | +21% | +8.4M shares |
| Available history | +31% | +11.4M shares |
CRNC has 48M diluted shares, up 10% from a year ago, despite $8M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $52,000 |
| Q1 2026 | $13,000 |
| Q4 2025 | $7.5M |
| Q3 2025 | $180,000 |
| Q2 2025 | $29,000 |
| Q1 2025 | $802,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $8,000 |
CRNC spent $8M buying back its own shares over the past year, about four times what it spent the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | 0.0x | Very low |
CRNC has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CRNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 31.1 | Neutral |
CRNC's weekly RSI is 45 (neutral) and its Stochastic is 31 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CRNC PE vs Technology Sector
| Metric | CRNC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNC has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CRNC on trend strength, trading above more of its moving averages.
CRNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 1.3% below |
| 20 week MA | $8.62 | 5.3% below |
| 50 week MA | $9.28 | 12% below |
| 100 week MA | $9.87 | 17% below |
| 200 week MA | $12.9 | 37% below |
CRNC is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CRNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $105.1 | +401% |
| 2021 | $105.1 | $78.9 | -25% |
| 2022 | $78.9 | $18.6 | -76% |
| 2023 | $18.6 | $19.7 | +5.9% |
| 2024 | $19.7 | $8.49 | -57% |
| 2025 | $8.49 | $11.1 | +30% |
| 2026 YTD | $11.1 | $8.16 | -26% |
CRNC has the edge over ASTS on returns for 2026, with the stronger performance.